Skip to main content
OpenTrials
Completed

NCT Number: NCT02475967

Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

In the trial cardiac patients will be provided with unrestricted access to the web-based eLearing platform for a one-month period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ZOL, Genk, Belgium

Loading trial locations.

About this study

Patients participating in the trial will be provided with a cardiac web-based eLearning platform for one month during study period. The medical content of the packages will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists).

E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence.

E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting

Exclusion criteria

  • Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content
  • (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages
  • Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages
  • Patients participating in another trial during the Pilot study period
  • Patients refusing to provide signed consent

Treatment and study plan

Intervention group

Other

The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.

Control Group

Other

The control group patients receive conventional cardiac care alone.

Primary outcomes

  1. Health-related quality of life

    Time frame: 3 months

    Health-related quality of life, assessed by HeartQol

Secondary outcomes

  1. Adherence to the E-learning packages

    Time frame: 3 months

    Adherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.

  2. Effectiveness of E-learning packages

    Time frame: 3 months

    Effectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.

  3. User experience of eLearning platform

    Time frame: 3 months

    Asses user experience of eLearning platform by User Experience Questionnaire (UEQ)

Sponsors and collaborators

Lead sponsor

Hasselt University

Other

Collaborators

  • Jessa Hospital

Registry information

Official study title

eEduHeart I: a Multi-center Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-based eLearning Platform

Acronym: eEduHeart I

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jun 19, 2015
Registry last updated
Feb 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.